A 35-year-old man with type 2 diabetes presents with fasting blood glucose of 180 mg/dL despite metformin therapy. His liver biopsy shows increased hepatic glycogen and elevated PEPCK expression. Which feature best distinguishes excessive hepatic gluconeogenesis from impaired glycolysis in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.